Repeatability and Reproducibility of Lens Zonule Length Measurement Using ArcScan Insight 100

Sponsor
Wenzhou Medical University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05657951
Collaborator
(none)
45
1
5
9

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the intra-examiner repeatability and inter-examiner reproducibility in lens zonule length measurements using very high-frequency (VHF) digital ultrasound (ArcScan Insight 100).

Condition or Disease Intervention/Treatment Phase
  • Device: ArcScan Insight 100 very high-frequency digital ultrasound

Study Design

Study Type:
Observational
Anticipated Enrollment :
45 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Repeatability and Reproducibility of Lens Zonule Length Measurement Using ArcScan Insight 100 Very High-frequency Digital Ultrasound
Actual Study Start Date :
Aug 1, 2022
Actual Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Normal eyes

Device: ArcScan Insight 100 very high-frequency digital ultrasound
The Insight-100 (ArcScan Inc., Golden, CO, USA) employs the high-frequency B-scan in the assessment of anterior segment parameters. Anormal saline coupling medium is formed with a disposable eyepiece between the 50 MHz transducer and the eye. The instrument moves the transducer in an arc so that the beam axis maintains approximate normality to the surface of the eye. The frequencies of cornea, anterior chamber, and lens are 60 MHz, 50 MHz and 50 MHz, respectively. The maximum arc scanning range is 70 degrees, and there is a linear scanning range of 29mm. The axial and lateral resolutions are 35 μm and 65 μm, respectively. It can measure structures behind the iris, including lens zonule.

Outcome Measures

Primary Outcome Measures

  1. Repeatability of ArcScan Insight 100 zonule scans in normal eyes (standard deviation and coefficient of variation) [1 day]

    First, three images will be obtained under'capsule model'using ArcScan Insight 100, and the length of zonule will be measured with built-in software by operator A. Operator B then performed the measurements using the same procedure and technique. The standard deviation and coefficient of variation of 3 repeated measurements for zonule length. will be calculated.

  2. Reproducibility of ArcScan Insight 100 zonule scans in normal eyes [1 day]

    First, three images will be obtained under'capsule model'using ArcScan Insight 100, and the length of zonule will be measured with built-in software by operator A. Operator B then performed the measurements using the same procedure and technique. The intraclass correlation is used to evaluate the difference between operator A and operator B.

Secondary Outcome Measures

  1. Repeatability of zonule length measurement with the built-in software (the intraclass correlation) [1 month]

    After a 1-month period, operator A and operator B will measure the zonule length again. The intraclass correlation is used to evaluate the difference between the two repeated measurements of one same image by Operator A or Operator B.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Subjects with no ocular disease except ametropia

  • Subjects will be able to understand and willing to sign an informed consent

Exclusion Criteria:
  • Previous ocular surgery

  • Subjects not being able to tolerate or not willing to use pilocarpine eye drops

  • Subjects has active ocular infection or inflammation

  • Subjects not being able to look steadily

  • Subjects not being able to open eyes wide in sterile saline even after topical anesthesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Hospital of WMU Hangzhou Zhejiang China 325027

Sponsors and Collaborators

  • Wenzhou Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yune Zhao, Vice president, Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT05657951
Other Study ID Numbers:
  • Insight100-zonule1
First Posted:
Dec 20, 2022
Last Update Posted:
Dec 20, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 20, 2022